Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ISCUP1 is annotated as a pseudogene, meaning it is a segment of DNA that resembles a gene but is typically non-functional and does not encode an active protein. There is no evidence for it being expressed as a functional protein, nor is it classified as a receptor, enzyme, transporter, or recognized therapeutic target[6]. Pseudogenes like ISCUP1 may arise from duplication or retrotransposition events and often accumulate mutations that disable protein coding. As a result, ISCUP1 should not be considered a viable molecule or receptor for therapeutic intervention, biomarker discovery, or drug targeting under current knowledge[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-sulfur cluster assembly enzyme pseudogene 1 (ISCUP1).